Empowering Cancer Survivors Through Information Technology

This is a randomized controlled trial of a web-based informational intervention (UMFollowUp) for adolescent and young adult survivors of childhood cancer to improve cancer knowledge and psychosocial functioning.

Study Overview

Status

Completed

Conditions

Detailed Description

Individuals randomly assigned to the control group will receive standard of care for the duration of their participation. This means they will continue to receive information regarding their diagnosis, treatments and ongoing health needs from their provider (no access to website).

Individuals randomly assigned to the treatment group will receive access to UMFollowUp, a secure, HIPAA-compliant website.

All participants will be asked to complete paper-and-pencil surveys at baseline and 9 months later to determine the impact of the web-based intervention.

Study Type

Interventional

Enrollment (Actual)

53

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55455
        • Masonic Cancer Center, University of Minnesota

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 28 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • History of diagnosis of hematologic malignancy or malignant neoplasm, and in disease free remission at time of recruitment.
  • Must be English-speaking and have access to a computer with internet access, and must have completed treatment at University of Minnesota Medical Center-Fairview for cancer.

Exclusion Criteria:

  • Individual with significant visual impairments and neurologic/cognitive difficulties which limit their ability to see and under our outcome questionnaires or website content will be excluded from participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Web-Based Intervention
UMFollowUp - web-based internet resource for information about their diagnostic histories, recommendations for follow-up care, and tips to enhance their treatment, psychosocial and physical well-being.
Web-based internet resource for self-reported treatment summaries and psychosocial and physical well-being.
Active Comparator: Standard of Care
Patients will receive information regarding their diagnosis, treatments, and ongoing health needs from their provider, but will not be provided access to the website.
Patients will receive information regarding their diagnosis, treatments, and ongoing health needs from their provider, but will not be provided access to the website.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cancer Knowledge Survey
Time Frame: Time of Enrollment and 9 Months Later
Measure of patient reported knowledge of their cancer diagnosis, history and treatments.
Time of Enrollment and 9 Months Later

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SF-36 Questionnaire
Time Frame: Time of Enrollment and 9 Months Later
A measure of quality of life.
Time of Enrollment and 9 Months Later
Cancer Rehabilitation Evaluation System
Time Frame: Time of Enrollment and 9 Months Later
Short Form (SF) Medical Interaction Subscale
Time of Enrollment and 9 Months Later
Herth Hope Index
Time Frame: Time of Enrollment and 9 Months Later
A measure of self-reported hope.
Time of Enrollment and 9 Months Later
Multidimensional Scale of Perceived Social Support
Time Frame: Time of Enrollment and 9 Months Later
A measure of self-reported social support.
Time of Enrollment and 9 Months Later
Health Locus of Control Scale
Time Frame: Time of Enrollment and 9 Months Later
A measure of self-reported locus of control.
Time of Enrollment and 9 Months Later
State Trait Anxiety Inventory
Time Frame: Time of Enrollment and 9 Months Later
A measure of self-reported anxiety.
Time of Enrollment and 9 Months Later

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alicia Kunin-Batson, M.D., Masonic Cancer Center, University of Minnesota

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2007

Primary Completion (Actual)

April 1, 2012

Study Completion (Actual)

April 1, 2012

Study Registration Dates

First Submitted

May 4, 2012

First Submitted That Met QC Criteria

May 7, 2012

First Posted (Estimate)

May 8, 2012

Study Record Updates

Last Update Posted (Actual)

December 2, 2017

Last Update Submitted That Met QC Criteria

November 29, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2007NT078

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer Survivor

Subscribe